Imprimis Pharma

Imprimis Pharma

Imprimis Pharma

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) Delivering customized and other novel medicines to physicians and patients TODAY at accessible prices.
Raised
$25.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$16,000,000
Post-IPO debt - 2017
SWK Funding
$9,800,000
Post-IPO equity - 2016
Team Size
1–10
Employees
$16,000,000 Post-IPO debt
otcmarkets , prnewswire

Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings

$9,800,000 Post-IPO equity
StreetInsider.com

Imprimis Pharma (IMMY) Reports $9.8M Private Placement of Common stock and Warrants